Clinical Trial Update: Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SRT as salvage therapy for brain oligoprogression in EGFR-mutant non-small cell lung cancer after failure of third-generation EGFR-TK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SRT

Snippet

Sponsor: Shanghai Cancer Hospital, China | Conditions: Lung Cancer Stage IV | Phase 2 | Status: UNKNOWN